Please Wait.....
Report
Canine Arthritis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
Market Report I 2026-01-27 I 148 Pages I Global Market Insights
The Global Canine Arthritis Treatment Market was valued at USD 3.8 billion in 2025 and is estimated to grow at a CAGR of 7.8% to reach USD 7.9 billion by 2035.
The market expansion is driven by the rising incidence of osteoarthritis (OA) in dogs. Canine arthritis treatment encompasses a range of therapies designed to manage joint pain, inflammation, and reduced mobility in dogs affected by osteoarthritis or other degenerative joint disorders. These treatments aim to alleviate discomfort, restore joint function, and improve overall well-being through individualized, multimodal approaches that match disease severity and the dog's specific needs. Options include pharmaceutical interventions such as NSAIDs, corticosteroids, and opioid pain relievers, along with newer biologic therapies like monoclonal antibodies, nutritional supplements including glucosamine and omega-3 fatty acids, physical therapy, and, in certain cases, surgical procedures. Adoption of multimodal treatment strategies has strengthened market growth, as combining medications, supplements, and physical therapies provides more comprehensive management for long-term joint health and improved mobility in dogs.
In 2025, the non-surgical treatments segment held a 77.1% share, generating USD 2.9 billion. This dominance reflects the growing preference among pet owners and veterinarians for non-invasive therapies, such as pharmaceuticals, monoclonal antibodies, supplements, and physical rehabilitation, before considering surgical intervention. Non-surgical approaches are also more cost-effective and accessible for managing chronic conditions over the long term. Increased awareness of disease prevention and the importance of slowing arthritis progression is encouraging broader adoption of these therapies among pet populations worldwide.
The osteoarthritis segment held 56.9% share in 2025. Osteoarthritis is one of the most common degenerative joint disorders in dogs, contributing significantly to the overall burden of canine arthritis. Rising OA prevalence across age groups emphasizes the need for effective, long-term management strategies, positioning osteoarthritis as the dominant segment in the canine arthritis treatment market.
North America Canine Arthritis Treatment Market accounted for 43.3% share in 2025. Market growth in this region is fueled by high pet ownership rates, substantial spending on veterinary care, and advanced veterinary infrastructure. A strong network of clinics, specialty hospitals, and diagnostic centers ensures early diagnosis and continuous management of chronic conditions such as arthritis. North American pet owners' willingness to invest in innovative treatments further drives the adoption of multimodal therapies and high-quality veterinary products.
Key players in the Global Canine Arthritis Treatment Market include Zoetis, VetriScience, Elanco Animal Health, Boehringer Ingelheim Animal Health, K9 Vitality, Dechra Pharmaceuticals, CEVA Sante Animale, Norbrook Laboratories, Nutramax Laboratories Veterinary Sciences, VetStem, Thorne Vet, Auburn Laboratories, Virbac, AdvaCare Pharma, Deley Naturals, American Regent, and JBT Corporation. Leading companies in the canine arthritis treatment market are implementing a range of strategies to strengthen their position and expand their market footprint. They are heavily investing in research and development to introduce innovative pharmaceuticals, biologics, and nutritional supplements tailored for canine joint health. Strategic partnerships with veterinary clinics, specialty hospitals, and distributors are being established to expand market access and provide localized support. Companies are also focusing on acquiring smaller firms with complementary technologies, allowing rapid portfolio expansion and entry into new geographies.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter's Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research approach
1.3 Quality commitments
1.3.1 GMI AI policy and data integrity commitment
1.3.1.1 Source consistency protocol
1.4 Research trail and confidence scoring
1.4.1 Research trail components
1.4.2 Scoring components
1.5 Data collection
1.5.1 Partial list of primary sources
1.6 Data mining sources
1.6.1 Paid sources
1.6.1.1 Sources, by region
1.7 Base estimates and calculations
1.7.1 Revenue share analysis
1.7.2 Base year calculation
1.8 Forecast model
1.9 Research transparency addendum
1.9.1 Source attribution framework
1.9.2 Quality assurance metrics
1.9.3 Our commitment to trust
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
2.2 Key market trends
2.2.1 Regional trends
2.2.2 Treatment type trends
2.2.3 Arthritis type trends
2.3 CXO perspectives: Strategic imperatives
2.3.1 Key decision points for industry executives
2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising pet ownership and humanization of pets
3.2.1.2 Increasing prevalence of osteoarthritis in dogs
3.2.1.3 Advancements in veterinary pharmaceuticals and therapies
3.2.1.4 Expansion of veterinary infrastructure and telemedicine
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of long-term treatment
3.2.2.2 Competition from alternative therapies
3.2.3 Market opportunities
3.2.3.1 Growing development and commercialization of next-generation therapies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.4.4 Latin America
3.4.5 Middle East and Africa
3.5 Canine population statistics, by country
3.6 Pipeline analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
4.1 Introduction
4.2 Company market share analysis
4.2.1 Global
4.2.2 North America
4.2.3 Europe
4.2.4 Asia Pacific
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Merger and acquisition
4.6.2 Partnership and collaboration
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2022 - 2035 ($ Mn)
5.1 Key trends
5.2 Non-surgical treatment
5.2.1 By type
5.2.1.1 Pharmaceuticals
5.2.1.1.1 Non-steroidal anti-inflammatory drugs (NSAIDs)
5.2.1.1.2 Corticosteroids
5.2.1.1.3 Opioid pain relievers
5.2.1.1.4 Other pharmaceuticals
5.2.1.2 Supplements
5.2.1.2.1 Glucosamine
5.2.1.2.2 Chondroitin
5.2.1.2.3 Methylsulfonylmethane
5.2.1.2.4 Other supplements
5.2.2 By route of administration
5.2.2.1 Oral
5.2.2.2 Injectable
5.2.2.3 Other routes of administration
5.2.3 By distribution channel
5.2.3.1 Veterinary hospital pharmacies
5.2.3.2 Retail pharmacies
5.2.3.3 Online pharmacies
5.3 Surgical procedures
5.4 Other treatment types
Chapter 6 Market Estimates and Forecast, By Arthritis Type, 2022 - 2035 ($ Mn)
6.1 Key trends
6.2 Osteoarthritis
6.3 Traumatic arthritis
6.4 Osteochondrosis
6.5 Rheumatoid arthritis
Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 Australia
7.4.5 South Korea
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 AdvaCare Pharma
8.2 American Regent
8.3 Auburn Laboratories
8.4 Boehringer Ingelheim Animal Health
8.5 CEVA Sante Animale
8.6 Dechra Pharmaceuticals
8.7 Deley Naturals
8.8 Elanco Animal Health
8.9 K9 Vitality
8.10 Norbrook Laboratories
8.11 Nutramax Laboratories Veterinary Sciences
8.12 Thorne Vet
8.13 Vetoquinol
8.14 VetriScience
8.15 VetStem
8.16 Virbac
8.17 Zoetis
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security